Incyte (INCY) Net Margin (2009 - 2026)
Incyte (INCY) reported Net Margin of -50.40% for Q3 2026, down 81.45 percentage points from 31.05% a year earlier and down 85.38 percentage points from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Net Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Incyte's Net Margin came in at 6.71%, down 17.98 percentage points year-over-year; for FY2025, it came in at 25.03%, up 24.26 percentage points from FY2024.
- Net Margin has a five-year change of +36.11 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at 0.77% in FY2024 (-15.40 pp), 16.17% in FY2023 (+6.14 pp), 10.04% in FY2022 (-21.73 pp) and 31.76% in FY2021 (+42.85 pp).
- The Q3 2026 figure ranks as the lowest quarterly Net Margin since Q1 2020.
- Year over year, Net Margin gained in five of the last eight quarters, with an average year-over-year change of +2.80 percentage points.
- The high point for year-over-year Net Margin in five years was Q2 2025 (a gain of 75.91 percentage points); the low point was Q3 2026 (a drop of 81.45 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 34.98% (Q2 2026), 23.83% (Q1 2026) and 19.86% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | -50.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -50.40% |
| Jun 30, 2026 | 34.98% |
| Mar 31, 2026 | 23.83% |
| Dec 31, 2025 | 19.86% |
| Sep 30, 2025 | 31.05% |
| Jun 30, 2025 | 33.32% |
| Mar 31, 2025 | 15.03% |
| Dec 31, 2024 | 17.07% |
| Sep 30, 2024 | 9.36% |
| Jun 30, 2024 | -42.60% |
| Mar 31, 2024 | 19.25% |
| Dec 31, 2023 | 19.84% |
| Sep 30, 2023 | 18.64% |
| Jun 30, 2023 | 21.32% |
| Mar 31, 2023 | 2.68% |
| Dec 31, 2022 | 3.07% |
| Sep 30, 2022 | 13.70% |
| Jun 30, 2022 | 17.71% |
| Mar 31, 2022 | 5.18% |
| Dec 31, 2021 | 65.35% |
API Access
Incyte Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();